Delivery Order SPE2DB20D3104-SPE2DB22FV6T9
Award Date
5/6/22
Potential Completion Date
5/9/22
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FL9X2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,778.42 firm fixed-price delivery order is for the supply of 4,559,444,350 units of hydroxychloroquine 200 mg tablets. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,632.85 delivery order contract is for the supply of hydroxychloroquine 200 mg tablets. The contract has a firm fixed price and a completion date of March 22, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Hydroxychloroquine 200 mg tablets. The $1,957.14 Firm Fixed Price Delivery Order is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,511.52 Firm Fixed Price contract is a Delivery Order that provides 4,561,170,454 units of hydroxychloroquine 200 mg tablets to support military and federal healthcare programs. The contract has a period of performance through June 8, 2023 and was awarded on June 7, 2023. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Hydroxychloroquine 200 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,408.15. The award date was March 28, 2022, with an ultimate completion date of March 29, 2022. The contract does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, worth $2,041.27, is for the supply of 4,560,423,676 units of Hydroxychloroquine 200 mg tablets. The contract has an ultimate completion date of March 30, 2023 and is a firm fixed-price arrangement. This award supports the healthcare needs of...
This federal contract award is for the delivery of hydroxychloroquine 200 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a parent company called Cencora, Inc. The contract has a ceiling value of $3,652.07 and was awarded on September 13, 2021, with a completion date of September 14, 2021. It is a firm fixed-price delivery order contract, with no set-aside designation....
This federal contract award is for the delivery of hydroxychloroquine 200 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a delivery order with a ceiling value of $2,447.91 and a firm fixed price pricing type. The contract has no set-aside designation, indicating it was awarded through full and open competition. The contract is...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,557,932,255 tablets of Hydroxychloroquine 200 mg, a critical pharmaceutical product. The Firm Fixed Price contract has a ceiling value of $8,276.28 and a completion date of July 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of hydroxychloroquine 200 mg tablets in 100-count bottles, with a ceiling value of $3,909.46 and a completion date of September 3, 2024. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...